Barely Significant
← all phrases

“showed a trend”

53,323 sentences · 53,323 papers · 65,371 search hits before verification

In the literature

Linagliptin 5 mg also showed a trend of nonsignificance to improve indexes of β-cell function, including fasting insulin, disposition index (DI), and homeostasis model assessment (HOMA) of IR. 25 Linagliptin as add-on therapy to one oral antidiabetic drug A 52-week, multicenter, open-label study evaluates the efficacy of linagliptin 5 mg once daily as add-on therapy to one background oral antidiabetic drug (OAD), including biguanide, glinide, glitazone, sulphonylurea (SU), and α-glucosidase inhibitor (A-GI), in 618 Japanese patients with T2DM inadequately controlled.
The clinical application of linagliptin in Asians.
Ther Clin Risk Manag · 2015 · PMC4577268
98 Although societies have grouped HCV-4 with HCV-1, there has been conflicting data as some studies showed a trend towards higher SVR rates in HCV-4 compared to HCV-1, 14 32 whereas other studies have not demonstrated any significant differences. 42 43 46 In our meta-analysis of studies directly comparing HCV-4 and HCV-1 patients, HCV-4 patients had significantly higher rates of RVR (OR 1.96, CI 1.64 to 2.35, p<0.001), but no statistically significant difference in SVR rates (53% vs 44%, OR 1.16 (CI 0.92 to 1.48, p=0.21)).
In addition, variants at several loci including ST6GAL1, ACCS , and ITGAX showed a trend of increasing risk allele frequencies from the African, European to Asian samples of the HapMap project, suggesting that they may contribute cumulatively to geographical differences in the genetic susceptibility and thus the disease prevalence of IgA nephropathy [ 2 , 3 ].
GWAS reveal novel IgA nephropathy risk loci.
Oncotarget · 2015 · PMC4599228
64 – 66 One such study showed a trend toward improvement in insulin sensitivity after CPAP therapy using the hyperinsulinemic–euglycemic clamp; however, the degree of improvement did not reach statistical significance. 67 It is possible that the failure to obtain a statistically significant result was because mean nightly usage of CPAP in that study was only 3.6 hours.
Although not differing significantly, the combination of COT plus UDCA showed a trend in reducing the risk of MOLT when compared with OBS (HR 2.05, 95% CI 0.50–8.93), monotherapy with UDCA (HR 2.63, 95% CI 0.72–10.75), COC plus UDCA (HR 2.55, 95% CI 0.44–15.03), MTX plus UDCA (HR 3.58, 95% CI 0.61–21.96), or BEF plus UDCA (HR 3.48, 95% CI 0.21–56.93).